No profile data available.
IceCure Medical Ltd (ICCM) is a healthcare company in the targeted healthcare equipment industry, based in Caesarea, Israel, with about 67 full-time employees.
It reported revenue of $3.38 million for fiscal year 2025, up 2.7% from fiscal year 2024, and net income of -$15.06 million. Other was its largest region in fiscal year 2025, with 57% of revenue. Its market capitalization was $5.10 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
IceCure Medical Ltd, a commercial-stage medical device company, engages in the research, development, and marketing of cryoablation systems, disposables, and technologies for treating tumors in the United States, Japan, India, China, Israel, and internationally.
IceCure Medical reported $3.38 million in revenue for fiscal year 2025, up 2.7% from $3.29 million in fiscal year 2024.
Other: 57% of revenue by region in fiscal year 2025, followed by United States (27%).
$5.10 million as of October 9, 2026.
Listed companies of a similar size in the same industry (targeted healthcare equipment) include CYduct Diagnostics, Inc. (CYDX), enVVeno Medical Corporation (NVNO), Autonomix Medical, Inc. (AMIX), Vivos Therapeutics, Inc. (VVOS).